Table 1 Data information on ALS patients and controls recruited in the study
ID number | Biopsy location | Sex | Age at sampling | Current age | Age of death | Clinical status | Genetic status |
|---|---|---|---|---|---|---|---|
SALS 1 | Arm | M | 48 | NA | 49 | Affected | No known ALS-associated mutations |
SALS 2 | Arm | M | 34 | NA | 34 | Affected | No known ALS-associated mutations |
SALS 3 | Arm | M | 64 | NA | 64 | Affected | No known ALS-associated mutations |
SALS 4 | Arm | F | 54 | NA | 54 | Affected | No known ALS-associated mutations |
SALS 5 | Arm | M | 59 | NA | 59 | Affected | No known ALS-associated mutations |
SALS 6 | Arm | F | 58 | NA | 58 | Affected | No known ALS-associated mutations |
C9-S000005 | Arm | F | 63 | 65 | NA | Clinically unaffected | C9orf72 expansion |
C9-S000008 | Arm | F | 47 | 49 | NA | Clinically unaffected | C9orf72 expansion |
C9-S000009 | Arm | F | 59 | 60 | NA | Affected | C9orf72 expansion |
C9-S000012 | Arm | M | 52 | 54 | NA | Clinically unaffected | C9orf72 expansion |
C9-S000013 | Arm | F | 49 | 51 | NA | Clinically unaffected | C9orf72 expansion |
C9-S000014 | Arm | M | 46 | 47 | NA | Clinically unaffected | C9orf72 expansion |
Ctrl 1 | Arm | F | 55 | NA | NA | Control | NA |
Ctrl 2 | Arm | F | 48 | NA | NA | Control | NA |
Ctrl 3 | Arm | M | 50 | NA | NA | Control | NA |
Ctrl 4 | Arm | M | 62 | NA | NA | Control | NA |
Mui638x | Arm | F | 38 | NA | NA | Control | NA |